1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Alfa Wassermann Tunisia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone Sulodexide, Statin, Antiplatelet Agents - Peripheral Arterial Obstructive Disease | Phase 3 | Unknown | Alfa Wassermann Tunisia | 156 | 2019-01-31 | 2019-12-02 |
Angiotensin-Converting Enzyme Inhibitors (1) · Atorvastatin (1) · Captopril (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Platelet Aggregation Inhibitors (1) · acetylsalicylic acid lysinate (1) · glucuronyl glucosamine glycan sulfate (1)
Tunisia (1)
Imed Frikha, MD (1)